In this retrospective case-control study of 1173 subjects with suspected pulmonary embolism, the 6-month rate of major adverse events (venous thromboembolic, major bleeding, or death) was lower following contrast-enhanced magnetic resonance angiography (MRA) (5.4%) than following computed tomographic angiography (CTA) (13.4%, p < 0.001). The technical success rate of MRA (92.6%) and CTA (90.5%) performed in a routine clinical setting did not differ significantly (p = 0.41). MRA is a clinically effective imaging exam for the primary evaluation of pulmonary embolism.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords